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Summary Following recommendations from a Health Technology
Assessment (HTA), a prospective cohort study of meticillin-resistant Staph-
ylococcus aureus (MRSA) screening of all admissions (N¼ 29 690) to six
acute hospitals in three regions in Scotland indicated that 7.5% of patients
were colonised on admission to hospital. Factors associated with colonisa-
tion included re-admission, specialty of admission (highest in nephrology,
care of the elderly, dermatology and vascular surgery), increasing age,
and the source of admission (care home or other hospital). Three percent
of all those who were identified as colonised developed hospital-associated
MRSA infection, compared with only 0.1% of those not colonised. Special-
ties with a high rate of colonisation on admission also had higher rates of
MRSA infection. Very few patients refused screening (11 patients, 0.03%)
or had treatment deferred (14 patients, 0.05%). Several organisational is-
sues were identified, including difficulties in achieving complete uptake
of screening (88%) or decolonisation (41%); the latter was largely due to
short duration of stay and turnaround time for test results. Patient
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movement resulted in a decision to decontaminate all positive patients
rather than just those in high risk specialties as proposed by the HTA. Issues
also included a lack of isolation facilities to manage patients with MRSA.
The study raises significant concerns about the contribution of decolonisa-
tion to reducing risks in hospital due to short duration of stay, and rein-
forces the central role of infection control precautions. Further study is
required before the HTA model can be re-run and conclusions redrawn
on the cost and clinical effectiveness of universal MRSA screening.
Introduction
Meticillin-resistant Staphylococcus aureus (MRSA)
infections are associated with greater risk of treat-
ment failure, increased patient mortality and
higher costs than infections with meticillin-
susceptible S. aureus.1,2 Within Europe, countries
with low endemicity are observing an increase in
the proportion of S. aureus cases due to MRSA;
Scotland and the rest of the UK continue to have
relatively high rates of MRSA, in common with Med-
iterranean countries, Romania and Ireland.3 MRSA
is a particular challenge in hospitals as patients
with wounds, invasive devices and weakened im-
mune systems are at greater risk of infection
than the general public.4
Uncertainty remains over the effectiveness of
any single control measure compared with an-
other, as they do not act independently and are
often implemented concurrently. The Society for
Healthcare Epidemiology of America guidelines
have noted that multiple studies implementing
surveillance, screening and contact precautions
have resulted in a significant reduction in the rates
of both MRSA colonisation and infection.5,6 Screen-
ing identifies patients who are either colonised or
infected, which allows targeted intervention to re-
duce the risk of endogenous infection and trans-
mission to others.
Universal screening of all patients for MRSA
continues to be controversial.7,8 The most recent
UK professional guidance on MRSA promotes tar-
geted screening, but this has not been imple-
mented in a consistent manner.9 Current MRSA
screening practice within Scotland is locally deter-
mined, and is generally targeted on the basis of
the perceived likelihood of MRSA carriage and
risk of infection.
Policy proposals for universal MRSA screening of
hospital patients have recently been developed in
UK countries.10 14 This process in Scotland followed
the publication of the National Health Service (NHS)
Quality Improvement Scotland Health Technology
Assessment (HTA) on the clinical- and cost-effec-
tiveness of MRSA screening.15 An MRSA screening
pilot study in Scotland was developed from the
HTA recommendations, using the UK National
Screening Committee screening criteria as a frame-
work. These interim results present the findings
from the first five months of data collection.
Methods
This was a prospective cohort study in six hospitals
in three regions (NHS Ayrshire and Arran, NHS
Grampian and NHS Western Isles Health Board
areas) in Scotland.
Participating hospitals followed the strategy
recommended by the HTA which, of the six possible
strategies investigated, was judged the most cost-
effective and clinically effective approach.15 This
strategy specified: screening all overnight admis-
sions in acute specialties (excluding obstetrics, psy-
chiatry and paediatrics); isolating patients
identified as MRSA positive (colonised or infected);
decolonising patients admitted to a specialty
deemed ‘high risk’; and isolating, but not decolonis-
ing, patients admitted to a ‘low risk’ specialty.
Each admission to hospital was considered as
a single patient episode, although multiple admis-
sions were monitored. Patients were categorised
as elective (arranged) or emergency admissions.
Elective patients were screened at pre-admis-
sion clinics where possible. Patients found to be
positive were provided with decolonisation ther-
apy (mupirocin nasal ointment three times daily,
and antiseptic bodywash, for five days). Elective
patients who remained unscreened were screened
on admission. Patients being admitted as emer-
gencies or through inter-hospital transfer were
screened on admission.
Screening staff were trained to take a nasal
swab correctly and compliance was monitored
throughout the study period. Any wounds or in-
vasive device sites were also sampled using sep-
arate swabs.
Swabs were plated on to chromogenic agar,
tested by latex slide test, and by a disc diffusion
test for antibiotic susceptibility. All results were
made available to staff on the laboratory reporting
systems immediately upon confirmation by labora-
tory staff. Positive MRSA results were communi-
cated directly to nurses on the wards.
MRSA-positive screens were reported to the
infection control team. Average turnaround time
was 48 h (range: 38 67). All patients who devel-
oped MRSA infection during their hospital stay
were identified according to Centers for Disease
Control and Prevention definitions.8 MRSA-positive
patients were isolated or cohorted. With patient
and clinician agreement, patients were com-
menced on decolonisation treatment where appro-
priate according to current guidelines.10
Data were analysed using Stata software, ver-
sion 9 at patient, specialty, hospital, NHS board
and overall study project levels. Descriptive statis-
tics are presented in this interim report.
Results
The demographics of patients from the six hospitals
(N¼ 29 690) inclusive of 15 081 admissions fromGram-
pian Health Board, 13 700 from Ayrshire and Arran and
909 from Western Isles are presented in Table I.
The overall prevalence of MRSA colonisation
during the study period was 7.47%, representing
the burden of patients requiring intervention at
any given point in time. Table II shows that 26 160
patients (88.1% of total hospital admissions) were
screened either at pre-admission clinics or on ad-
mission and, of these, 988 (3.78%) were found to
be positive for either MRSA colonisation or
Table I Summary demographics by Pathfinder NHS Board
Ayrshire & Arran Grampian Western Isles Total
Total patient admissions (%)a 13 700 (46.1) 15 081 (50.8) 909 (3.1) 29 690
Female (%) 7241 (53.1) 7811 (51.8) 446 (49.1) 15 498 (52.3)b
Male (%) 6400 (46.9) 7262 (48.2) 462 (50.9) 14 124 (47.7)
Age (years), range (median) 16e108 (63) 16e108 (61) 16e106 (70) 16e108 (62)
Emergency admissions (%) 10 743 (78.4) 8786 (58.3) 692 (76.1) 20 221 (68.1)
Elective admissions (%) 2901 (21.2) 6265 (41.5) 213 (23.4) 9379 (31.6)
Admitted from home (%) 13 057 (96.8) 13 862 (92.1) 816 (90.2) 27 735 (94.2)
Admitted from hospital (%) 108 (0.8) 475 (3.2) 40 (4.4) 623 (2.1)
Admitted from care home (%) 245 (1.8) 242 (1.6) 41 (4.5) 528 (1.8)
No. of patient re-admissions (%) 2561 (18.7) 2029 (13.5) 171 (18.8) 4761 (16.0)
Total patients screened (%) 11 483 (83.8) 13 777 (91.3) 900 (99.0) 26 160 (88.1)
Patients MRSA-positive on admission (%) 1043 (7.6) 1102 (7.3) 73 (8.0) 2218 (7.5)
Patients with MRSA infection on admission (%) 39 (0.28) 58 (0.38) 1 (0.11) 98 (0.33)
NHS, National Health Service; MRSA, meticillin-resistant Staphylococcus aureus.
a Total patient admissions recorded by pathfinder auditors during the study period from 1 August until 31 December 2008.
Patient capture varied by pathfinder site but was 88.1% overall.
b Where numbers do not add up to total admissions, details were unknown or not recorded.
Table II MRSA admission events: numbers and percentages at point of observation
Point of observation Total no. (%) patient admissions 95% CI
A. Pre-admission screen positive 55 (0.24) 0.18e0.31
B. Decolonisation pre-admission 5 (0.02) 0.002e0.03
C. Overall pre-admission or admission screen positive 988 (3.78) 3.52e4.03
D. Known on admission (previous positive MRSA from case notes) 1727 (5.87) 5.53e6.21
E. Total burden of MRSA positive (previous positive
pre-admission screen not decolonised, admission
screen positive, previous MRSA infection).
Patient admissions in more than one category have
not been double-counted.
2218 (7.47) 7.10e7.84
MRSA, meticillin-resistant Staphylococcus aureus; CI, confidence interval.
infection. Infections were most frequently skin/
soft tissue and surgical site infection. However,
the total number of patients competing for isola-
tion facilities on admission was 2218 (7.47%), inclu-
sive of those previously known to be MRSA positive
(5.87% of admissions). Over time, the number of
known positives rose due to screening activity.
From a total of 9379 elective admissions, 2287
(24.4%) attended pre-admission clinics. Of the 2215
screened at pre-admission, 52 (2.35% of pre-admis-
sion screens, 0.24% of the total admission population)
were found to have MRSA colonisation or infection.
Only five (9.61%) patients who were positive at pre-
admission (0.02% of total admission population) were
recorded as being successfully decolonised.
Overall, 405 out of 988 patients screening
positive commenced decolonisation therapy, but
only 41 patients (4.1% of all positive screens) were
successfully decolonised, and received three con-
secutive negative test results 48 h apart.
MRSA colonisation prevalence varied with spe-
cialty (Figure 1). Nephrology, care of the elderly,
dermatology and vascular surgery had the highest
proportion of MRSA-colonised admissions
(17 20%). Other factors influencing colonisation
status on admission are described in Table III.
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Figure 1 Proportion of patients meticillin-resistant Staphylococcus aureus positive on admission by admission
specialty (N¼ 2184).
The MRSA infection incidence during the study
was 0.3% (97 admissions). The highest MRSA in-
fection rates were in anaesthesia (2.94%), nephrol-
ogy (2.04%), diabetes medicine (1.75%) and
vascular surgery (1.53%). Less than a tenth (7.5%)
of all infections were bloodstream infections.
Three percent of those who developed health-
care-associated (HA) MRSA infection were positive
at admission or pre-admission clinics, compared
with 0.1% who screened negative.
Discussion
This is the first UK pilot study for a national MRSA
screening programme. The total prevalence of
MRSA colonisation at time of admission was found
to be 7.5%. The percentage of patients identified
as colonised by screening was 3.8% but, in addi-
tion, 5.9% of admissions (screened or not) were
known previous MRSA positives. Prevalence of
MRSA colonisation is defined in different ways in
the published literature, which makes comparisons
difficult but highlights the need for consis-
tency.1,8,16 Studies published since the HTA have
indicated an observed colonisation prevalence of
5.1% in all patients in a Swiss teaching hospital,
6.7% in a study of emergency patients and 5.1%
in surgical patients in the UK.8,16,17
Higher age, particular clinical specialties, emer-
gency admission, admission from other hospitals or
care homes, and a history of multiple admissions
were all found to be associated with higher risks of
MRSA colonisation.
Patients aged >65 years were more likely to be
colonised on admission to hospital (11.5% 65
years vs 4.4% <65 years); there was no statistically
significant difference between males and females.
These findings are consistent with other re-
ports.1,18 21 Colonisation prevalence also varied
by hospital (6 9%) and by specialty (0 20.3%).
The specialties with the highest prevalences
(17 20%) were nephrology, care of the elderly,
dermatology and vascular surgery. Caution must
be used in interpreting these figures, however, as
the higher risk specialties generally have longer
durations of stay, and some additional cases may
have been excluded at this interim stage in our
study. Nonetheless, the colonisation burden of
one in five patients indicates that these are spe-
cialties which are priority areas for screening, de-
spite an absence of evidence for universal
screening.
Colonisation prevalence varied between elec-
tive patients (2.4% of all pre-admission screens)
and emergency admissions (4.3% all emergency
patients screened on admission). However, only
a quarter of elective admissions in the study (7.5%
of all admissions) were screened at pre-admission
clinics; of these, 2.35% were found to be colonised
and only a small proportion of these patients
(9.6%) were successfully decolonised before
admission. The observed uptake (97%) and ease
of capturing these patients is therefore counter-
balanced by the low yield of positives identified
and decolonised, as well as the low colonisation
rate and the small proportion of total patients in
this group. It proved challenging to capture
patients seen pre-admission at general outpatient
clinics. Any added benefit of pre-admission screen-
ing is also affected by the timing of clinics, relative
to decolonising and re-testing prior to admission.
Previous MRSA colonisation is a recognised risk
factor for an MRSA-positive screen, and was found
in 5.9% of admissions in the study. Admission from
care homes or other hospitals has been associated
with higher colonisation risk, confirmed by the
current study (25% and 7.5% respectively).22,23
However, transfers from care homes or other hos-
pitals represented only a small proportion (3.8%)
of all admissions. In line with the HTA assumption,
the proportion of patients with known MRSA status
increased over the study period, due to increasing
ascertainment in patients with multiple admissions
which, of itself, may be a risk factor for colonisa-
tion. This raises the issue of continuing decolonisa-
tion regimens post discharge, for which there is no
current national guidance, in order to minimise the
Table III Risk factors for MRSA colonisation on
admission
N Total burden
of MRSA þvea
% MRSA þve
Age
<65 years 16 765 726 4.3
>65 years 12 922 1490 11.5
Gender
Male 14 124 1122 7.9
Female 15 498 1090 7.0
Admission type
Elective 9379 478 5.1
Emergency 20 221 1732 8.6
Admitted from
Home 27 735 1913 6.9
Care home 528 194 36.7
Hospital 623 79 12.7
Admission events
First admission 24 929 1620 6.5
Repeat admission 4761 598 12.6
MRSA, meticillin-resistant Staphylococcus aureus.
a Total burden of MRSA positives as defined in Table II (E).
risk of persistent colonisation on re-admission.
During the five months of the study, 16% of total
admissions were re-admissions and almost one-
third of all MRSA-positive admissions were re-
admissions.
This interim analysis does not examine all risk
factors for colonisation and, as such, cannot
generate a full clinical risk assessment (CRA).
The potential importance of CRA is supported by
our observation that almost three-quarters of
those patients admitted who were pre-emptively
isolated on the basis of CRA were found to be
positive thereafter by nasal screening. This obser-
vation varied by healthcare board within the study,
which may reflect the variation in CRA tools used.
The incidence of MRSA infections was 0.3% (109
infections in 98 patients). Around half were HAMRSA
and half were community-acquired MRSA. This is
broadly consistentwith other reports.17 Skin and soft
tissue infections were the most common type of in-
fection, followed by surgical infections. It should
be noted that the observed rates are likely to be an
underestimate of infection rates as some long-stay
patients may have been excluded from the study as
they remained non-discharged, and post-discharge
infections were not within the scope of the study.
Three percent of those who developed HA MRSA in-
fection were colonised on admission, compared
with 0.1% of those screened negative on admission.
Patients in anaesthetics, nephrology, diabetes med-
icine and vascular surgery specialties were more
likely to develop MRSA infections, being specialties
with patient case-mix and interventions associated
with increased risk of MRSA.
The screening programme in the study hospitals
to date resulted in very few patient refusals for
screening (11 patients, 0.03%) or treatment de-
ferrals (14 patients, 0.05%). However, a number of
practical organisational issues were identified.
Patient movement within the hospital between
low and high risk specialty wards made selective
decolonisation a challenge and a decision was
taken to decolonise all MRSA positive patients.
Organisational issues also included a lack of single
room facilities to manage patients with MRSA. The
HTA assumed 3 isolation rooms per 25 bed ward for
MRSA patients. This study found an uneven distri-
bution of rooms between wards and competing
priorities for the use of these rooms. Most patients
(78%) were cohorted or separated from other
patients during their stay, a practice which is
widespread but carries little supporting evidence
of effectiveness, and some were managed on open
wards. This reinforces the crucial importance of all
staff using Standard Infection Control Precautions
at all times for all patients.
Operational issues also included difficulties in
achieving full uptake of screening (88% achieved),
and compliance with decolonisation (only 41% of
MRSA-positive patients had decolonisation initi-
ated). The latter was mostly due to short durations
of admission and minimum two day turnaround
time for obtaining screening results from the
laboratory.24 Only 4.1% of known MRSA positives
were documented as having been successfully de-
colonised. These findings, in combination with
false negative test results and the relatively low
effectiveness of current decolonisation techniques
raise significant concerns about the small propor-
tion of colonised patients actually being rendered
MRSA-negative, both in terms of staffing and finan-
cial resource use and, critically, the real reduction
in risk achieved.15
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